Keyphrases
4-fold
20%
Bone Lesions
20%
CD11c
20%
Cell-to-cell
100%
Clinical High Risk
20%
Current Therapies
20%
Dendritic Cells
100%
Extensive Disease
20%
FMS-like Tyrosine Kinase 3 (FLT3)
60%
Fms-like Tyrosine kinase-1
20%
Granulocyte Colony-stimulating Factor (G-CSF)
80%
Histiocytosis X
20%
HLA-DR
20%
Immunosuppression
20%
Langerhans Cell Histiocytosis
100%
Langerhans Cells
40%
Lesion Formation
20%
Macrophages
40%
Multisystem Involvement
20%
Myeloid Dendritic Cells
100%
Novel Therapeutic Targets
20%
Proliferative Disorder
20%
Serum Cytokines
20%
Serum Levels
20%
Stem Cell Factor
40%
Medicine and Dentistry
APC
16%
Bone Lesion
16%
Colony Stimulating Factor 1
66%
Cytokine
66%
Dendritic Cell
100%
Diseases
50%
Immunosuppressive Treatment
16%
Langerhans Cell
33%
Langerhans Cell Histiocytosis
100%
Macrophage
33%
Myeloid Dendritic Cell
100%
Precursor
33%
Protein Tyrosine Kinase
16%
Prothrombin
16%
Stem Cell Factor
33%
Immunology and Microbiology
Antigen-Presenting Cell
14%
Blood Level
14%
CD11c
14%
Cytokine
57%
Dendritic Cell
100%
HLA-DR
14%
Immunosuppression
14%
Langerhans Cell
100%
Macrophage
28%
Macrophage Colony-Stimulating Factor
57%
Myeloid
14%
Myeloid Dendritic Cell
100%
Precursor
28%
Stem Cell Factor
28%
Tyrosine
14%
Biochemistry, Genetics and Molecular Biology
Blood Level
14%
CD11c
14%
Cytokine
57%
Dendritic Cell
100%
HLA-DR
14%
Langerhans Cell
100%
Macrophage
28%
Macrophage Colony-Stimulating Factor
57%
Myeloid
100%
Precursor
28%
Receptor Tyrosine Kinase
14%
Stem Cell Factor
28%
Tyrosine Kinase
14%
Pharmacology, Toxicology and Pharmaceutical Science
APC
16%
Bone Lesion
16%
Colony Stimulating Factor 1
66%
Cytokine
66%
Diseases
50%
Langerhans Cell Histiocytosis
100%
Protein Tyrosine Kinase
16%
Prothrombin
16%
Stem Cell Factor
33%